Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.
about
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, DTriple-combination therapy in the treatment of hypertension: a review of the evidence.Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control.Efficacy and tolerability of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide: a subgroup analysis of patients stratified by hypertension severity, age, sex, and obesity.
P2860
Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Combined olmesartan, amlodipin ...... s of the TRINITY study by age.
@en
type
label
Combined olmesartan, amlodipin ...... s of the TRINITY study by age.
@en
prefLabel
Combined olmesartan, amlodipin ...... s of the TRINITY study by age.
@en
P2093
P2860
P1433
P1476
Combined olmesartan, amlodipin ...... s of the TRINITY study by age.
@en
P2093
Andrew J Lewin
Joseph L Izzo
Michael Melino
Reinilde Heyrman
Victor Fernandez
P2860
P2888
P304
P356
10.1007/S40266-013-0072-1
P577
2013-07-01T00:00:00Z